Cyclodextrins in topical drug formulations: theory and practice

被引:374
作者
Loftsson, T [1 ]
Masson, M [1 ]
机构
[1] Univ Iceland, Fac Pharm, IS-107 Reykjavik, Iceland
关键词
cyclodextrin; permeability; drug delivery; topical;
D O I
10.1016/S0378-5173(01)00761-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclodextrins are cyclic oligosaccharides with a hydrophilic outer surface and a somewhat lipophilic central cavity. Cyclodextrins are able to form water-soluble inclusion complexes with many lipophilic water-insoluble drugs. In aqueous solutions drug molecules located in the central cavity are in a dynamic equilibrium with free drug molecules. Furthermore, lipophilic molecules in the aqueous complexation media will compete with each other for a space in the cavity. Due to their size and hydrophilicity only insignificant amounts of cyclodextrins and drug/cyclodextrin complexes are able to penetrate into lipophilic biological barriers, such as intact skin. In general, cyclodextrins enhance topical drug delivery by increasing the drug availability at the barrier surface. At the surface the drug molecules partition from the cyclodextrin cavity into the lipophilic barrier. Thus, drug delivery from aqueous cyclodextrin solutions is both diffusion controlled and membrane controlled. It appears that cyclodextrins can only enhance topical drug delivery in the presence of water. (C) 2001 Elsevier Science B.V. All rights, reserved.
引用
收藏
页码:15 / 30
页数:16
相关论文
共 142 条
[91]   Cyclodextrins as permeation enhancers:: some theoretical evaluations and in vitro testing [J].
Másson, M ;
Loftsson, T ;
Másson, G ;
Stefánsson, E .
JOURNAL OF CONTROLLED RELEASE, 1999, 59 (01) :107-118
[92]   Cyclodextrins in transdermal and rectal delivery [J].
Matsuda, H ;
Arima, H .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (01) :81-99
[93]   Low intensity ultrasound as a probe to elucidate the relative follicular contribution to total transdermal absorption [J].
Meidan, VM ;
Docker, M ;
Walmsley, AD ;
Irwin, WJ .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :85-92
[94]   Cyclodextrins in nasal drug delivery [J].
Merkus, FWHM ;
Verhoef, JC ;
Marttin, E ;
Romeijn, SG ;
van der Kuy, PHM ;
Hermens, WAJJ ;
Schipper, NGM .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (01) :41-57
[95]   MECHANISTIC STUDY OF ULTRASONICALLY-ENHANCED TRANSDERMAL DRUG-DELIVERY [J].
MITRAGOTRI, S ;
EDWARDS, DA ;
BLANKSCHTEIN, D ;
LANGER, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (06) :697-706
[96]   THE DEVELOPMENT OF A PREDICTIVE METHOD FOR THE ESTIMATION OF FLUX THROUGH POLYDIMETHYLSILOXANE MEMBRANES .1. IDENTIFICATION OF CRITICAL VARIABLES FOR A SERIES OF SUBSTITUTED BENZENES [J].
MOECKLY, DM ;
MATHESON, LE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 77 (2-3) :151-162
[97]   In vitro release study of tretinoin from tretinoin/cyclodextrin derivative complexes [J].
Montassier, P ;
Duchene, D ;
Poelman, MC .
JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY, 1998, 31 (03) :213-218
[98]  
Morita Y, 1996, CRS BUI NAT, P451
[99]  
OKAMOTO H, 1986, INT J PHARM, V30, P35, DOI 10.1016/0378-5173(86)90133-X
[100]   Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits [J].
Pate, DW ;
Järvinen, K ;
Urtti, A ;
Mahadevan, V ;
Järvinen, T .
LIFE SCIENCES, 1998, 63 (24) :2181-2188